L-arginine metabolism in early-onset and late-onset pre-eclamptic pregnancies

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 73, Issue 5, 2013, Pages 436-443

  Tamás, Péter ^a,b   Bódis, József ^b   Sulyok, Endre ^a   Kovács, Gábor L ^c   Hantosi, Eszter ^a,b   Molnár, Gábor ^b   Martens Lobenhoffer, Jens ^d   Bode Böger, Stefanie M ^d  

^a Faculty of Health Sciences   (Hungary)

^b UNIVERSITY OF PÉCS   (Hungary)

^c UNIVERSITY OF PÉCS   (Hungary)

^d OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Cord blood; L arginine; L methylarginines; L ornithine; Pre eclampsia

Indexed keywords

6 N,N' DIMETHYLARGININE; ARGININE; N(G) METHYLARGININE; N(G),N(G) DIMETHYLARGININE; ORNITHINE;

ADULT; APGAR SCORE; ARTICLE; BLOOD LEVEL; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; GESTATIONAL AGE; HEMATOCRIT; HUMAN; HYPERTENSION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MATERNAL PLASMA; MEAN ARTERIAL PRESSURE; METABOLISM; NEWBORN INTENSIVE CARE; PLACENTA WEIGHT; PREECLAMPSIA; PREGNANT WOMAN; PRIORITY JOURNAL; PROTEINURIA; SYSTOLIC BLOOD PRESSURE; THROMBOCYTE COUNT; UMBILICAL CORD BLOOD; VENOUS PRESSURE;

EID: 84882418026     PISSN: 00365513     EISSN: 15027686     Source Type: Journal    
DOI: 10.3109/00365513.2013.803230     Document Type: Article

References (51)

1. Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol 2009; 3 : 130-7.
2. Myatt L, Webster RP. Vascular biology of pre-eclampsia. J Thromb Haemost 2009; 7 : 375-84.
3. Redman CW, Sargent IL. Placental stress and pre-eclampsia: arevised view. Placenta 2009; 30 : 473-82.
4. Kobayashi T, Tokunaga N, Isoda H, Kanayama N, Terao T. Vasospasms are characteristic in cases with eclampsia/pre-eclampsia and HELLP syndrome: proposal of an angiospastic syndrome of pregnancy. Semin Thromb Hemost 2001; 27 : 131-5.
5. Huppertz B. Placental origins of pre-eclampsia: challenging the current hypothesis. Hypertension 2008; 51 : 970-5.
6. Roberts JM. Objective evidence of endothelial dysfunction in pre-eclampsia. Am J Kidney Dis 1999; 33 : 992-4.
7. Moffett A, Hiby SE. How does the maternal immune system contribute to the development of pre-eclampsia. Placenta 2007; 28(Suppl. A) : S51-6.
8. Hubel CA. Oxidative stress in the pathogenesis of preeclampsia. Proc Soc Exp Biol Med 1999; 222 : 222-5.
9. Sladek SM, Magness RR, Conrad KP. Nitric oxide and pregnancy. Am J Physiol 1997; 272 : R441-3.
10. Khalil RA, Granger JP. Vascular mechanisms of increased arterial pressure in pre-eclampsia: lessons from animal models. Am J Physiol Regul Integr Comp Physiol 2002; 283 : R29-45.
11. Böger RH, Diemert A, Schwedhelm E, Lüneburg N, Maas R, Hecker K. The role of nitric oxide synthase inhibition by asymmetric dimethylarginine in the pathophysiology of pre-eclampsia. Gynecol Obstet Invest 2010; 69 : 1-13.
12. Forstermann U, Closs E, Pollock JS, Nakane M, Schwarz P, Gath I, Kleinert H. Nitric oxide synthase isoenzymes: characterization, purifi cation, molecular cloning, and functions. Hypertension 1994; 23 : 1121-31.
13. Vallance P, Leone A, Calver A, Collier J, Moncada S. Accumulation of an endogenous inhibitor of NO synthesis in chronic renal failure. Lancet 1992; 339 : 572-5.
14. Böger RH, Sydow K, Borlak J, Thum T, Lenzen H, Schubert B, Tsikas D, Bode-Böger SM. LDL cholesterol upregulates synthesis of asymmetric dimethylarginine in human endothelial cells: involvement of S- adenosylmethionine-dependent methyltransferases. Circ Res 2000; 87; 99-105.
15. Cooke JP. Does ADMA cause endothelial dysfunction Arterioscler Thromb Vasc Biol 2000; 20 : 2032-2037.
16. Böger RH. The emerging role of asymmetric dimethylarginine as anovel cardiovascular risk factor. Cardiovasc Res 2003; 59 : 824-33.
17. Calver A, Collier J, Leone A, Moncada S, Vallance P. Effect of local intra-arterial asymmetric dimethylarginine (ADMA) on the forearm arteriolar bed of healthy volunteers. J Human Hypertens 1993; 7 : 193-4.
18. Böger R, Lentz SR, Bode-Böger SM, Knapp HR, Haynes WG. Elevation of asymmetric dimethylarginine may mediate endothelial dysfunction during experimental hyperhomocyst (e)inaemia in humans. Clin Sci 2001; 100 : 161-7.
19. Closs EI, Bascha FZ, Habermeier A, Forstermann U. Interferences of l-arginine analogues with l-arginine transport mediated by the ycarrier hCAT-2B. Nitric Oxide 1997; 1 : 65-73.
20. MacAllister RJ, Parry H, Kimoto M, Ogawa T, Russel RJ, Hodson H, Whitley GS, Vallance P. Regulation of nitric oxide synthesis by dimethylarginine dimethylaminohydrolase. BrJ Pharmacol 1996; 119 : 1533-40. Pettersson
21. A, Hedner T, Milsom I. Increased circulatory concentrations of asymmetric dimethyl arginine (ADMA), an endogenous inhibitor of nitric oxide synthesis, in preeclampsia. Acta Obstet Gynecol Scand 1998, 77 : 808-13.
22. Kim YJ, Park HS, Lee HY, Ha EH, Suh SH, Oh SK, Yoo HS. Reduced l-arginine level and reduced placental eNOS activity in pre-eclampsia. Placenta 2006; 27 : 438-44.
23. Lowe DT. Nitric oxide dysfunction in the pathophysiology of pre-eclampsia. Nitric Oxide 2000; 4 : 441-58.
24. Fickling SA, Williams D, Vallance P, Nussey SS, Whitley GS. Plasma concentrations of endogenous inhibitor of nitric oxide synthesis in normal pregnancy and pre-eclampsia. Lancet 1993; 342 : 242-3.
25. Holden DP, Fickling SA, Whitley GS, Nussey SS. Plasma concentration of asymmetric dimethylarginine, anatural inhibitor of nitric oxide synthase, in normal pregnancy and pre-eclampsia. Am J Obstet Gynecol 1998; 178 : 551-6.
26. Speer PD, Powers AW, Frank MP, Harger G, Markovic N, Roberts JM. Elevated asymmetric dimethylarginine concentrations precede clinical pre-eclampsia, but not pregnancies with small-for-gestational age infant. Am J Obstet Gynecol 2008; 198 : 112e1-7.
27. Wang Y, Gu Y, Zhang Y, Lewis D. Evidence of endothelial dysfunction in pre-eclampsia: decreased endothelial nitric oxide synthase expression is associated with increased cell permeability in endothelial cells from pre-eclampsia. Am J Obstet Gynecol 2004; 190 : 817-24.
28. Schiessl B, Mylonas I, Hantschmann P, Kuhn C, Schulze S, Kunze S, Friese K, Jeschke U. Expression of endothelial NO synthase, inducible NO synthase, and estrogen receptors alpha and beta in placental tissue of normal, pre-eclamptic, and intrauterine growth-restricted pregnancies. J Histochem Cytochem 2005; 53 : 1441-9.
29. Akbar F, Heinonen S, Pirskanen M, Uimari P, Tuomainen TP, Salonen JT. Haplotypic association of DDAH1 with susceptibility to pre-eclampsia. Mol Hum Reprod 2004; 11 : 73-7.
30. Wang Z, Tang WWH, Cho L, Brennan DM, Hazen SL. Targeted metabolomic evaluation of arginine methylation and cardiovascular risks. Potential mechanisms beyond nitric oxide synthase inhibition. Arterioscler Thromb Vasc Biol 2009; 29 : 1383-91.
31. Noris M, Todeschini M, Cassis P, Pasta F, Cappellini A, Bonazzola S, Macconi D, Maucci R, Porrati F, Benigni A, Picciolo L, Remuzzi G. L-arginine depletion in pre-eclampsia orients nitric oxide synthase toward oxidant species. Hypertension 2004; 43 : 614-22.
32. Raymond D, Peterson E. Acritical review of early-onset and late-onset pre-eclampsia. Obstet Gynecol Surv 2011; 66 : 497-506.
33. Martens-Lobenhoffer J, Bode-Böger SM. Fast and effi cient determination of arginine, symmetric dimethylarginine and asymmetric dimethylarginine in biological fl uids by hydrophillic-interaction liquid chromatography-electrospray tandem mass spechometry. Clin Chem 2006; 42 : 488-93.
34. Martens-Lobenhoffer J, Postel S, Troger U, Bode-Böger SM. Determination of ornithine in human plasma by hydrophilic interaction chromatography-electrospray tandem mass spectroscopy. J Chromatogr 2007; 855 : 271-5.
35. J enkinson CP, Grody WW, Cederbaum SP. Comparative properties of arginases. Comp Biochem Physiol 1996; 114B : 107-32.
36. Bachetti T, Comini L, Francolini G, Bastianon D, Valetti B, Cadei M, Grigolato P, Suzuki H, Finazzi D, Albertini A, Curello S, Ferrari R. Arginase pathway in human endothelial cells in pathophysiological conditions. J Mol Cell Cardiol 2004; 37 : 515-23.
37. Li H, Meininger CJ, Hawker JR, Haynes TE, Kepka-Lenhart D, Mistry SK, Morris SM Jr, Wu G. Regulatory role of arginase Iand II in nitric oxide, polyamine, and proline synthesis in endothelial cells. Am J Physiol Endocrinol Metab 2001; 280 : E75-82.
38. Berka V, Wu G, Yeh HC, Palmer G, Tsai AL. Three different oxygen-induced radical species in endothelial nitric oxide synthase oxygenase domain under regulation by arginine and tetrahydrobiopterin. J Biol Chem 2004; 279 : 32243-51.
39. Durante W, Johnson FK, Johnson RA. Arginase: acritical regulator of nitric oxide synthesis and vascular function. Clin Exp Pharm Physiol 2007; 34 : 906-11.
40. McDonald KK, Zharikov S, Block ER, Kilberg MS. Acaveolar complex between the cationic amino acid transporter Iand endothelial nitric-oxide synthase may explain the " arginine paradox ". J Biol Chem 1997; 272 : 31213-6.
41. Buga GM, Singh R, Pervin S, Rogers NE, Schmitz DA, Jenkinson CP, Cederbaum SD, Ignarro LJ. Arginase activity in endothelial cells: Inhibition by Nhydroxy-l-arginine during high-output NO production. Am J Physiol 1996; 271 : H1988-98.
42. Thein TW, Zhang C, Wang W, Chang CI, Thengchaisri N, Kuo L. Ischemia-reperfusion selectively impairs nitric oxidemediated dilatation in coronary arterioles: counteracting role of arginase. FASEB J2003; 17 : 2328-30.
43. Huynh NN, Chin-Dusting J. Amino acids, arginase and nitric oxide in vascular health. Clin Exp Pharm Physiol 2006; 33 : 1-8.
44. Ueda S, Kato S, Matsuoka H, Kimoto M, Okuda S, Morimatsu M, Imaizumi T. Regulation of cytokin-induced nitric oxide synthesis by asymmetric dimethylarginine: role of dimethylarginine dimethylaminohydrolase. Circ Res 2003; 92 : 226-33.
45. Sydow K, Münzel T. ADMA and oxidative stress. Atherosclerosis 2003; 4(Suppl. 4) : 41-51.
46. Nelin L, Nash H, Chicoine L. Cytokin treatment increases arginine metabolism and uptake in bovine pulmonary artery arterial endothelial cells. Am J Physiol Lung Cell Mol Physiol 2001; 281 : L1232-9.
47. Sankaralingam S, Xu H, Davidge ST. Arginase contributes to endothelial cell oxidative stress in response to plasma from women with pre-eclampsia. Cardiovasc Res 2010; 85 : 194-203.
48. Facchinetti F, Longo M, Piccinini F, Neri I, Volpe A. L-arginine infusion reduces blood pressure in pre-eclamptic women through nitric oxide release. J Soc Gynecol Invest 1999; 6 : 202-7.
49. Staff AC, Berge L, Haugen G, Lorentzen B, Mikkelsen B, Henriksen T. Dietary supplementation with l-arginine or placebo in women with pre-eclampsia. Acta Obstet Gynecol Scand 2004; 83 : 103-7.
50. Vadillo-Ortega F, Perichart-Perera O, Espino S, Avila-Vergara MA, Ibarra I, Ahued R, Godines M, Parry S, Macones G, Strauss JF. Effect of supplementation during pregnancy with L-arginine and antioxidant vitamins in medical food on pre-eclampsia in high-risk population: randomised controlled trial. Brit Med J2011; 342 : d2901.
51. Smeeth L, Williams D. Can adietary supplement prevent pre-eclampsia L-arginine with vitamins show promise, but there are good grounds for caution. BMJ 2011; 342 : d2777.